Loading...

Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy

BACKGROUND: Hearing loss is common following chemoradiotherapy for children with medulloblastoma. Compared to photons, proton radiotherapy reduces radiation dose to the cochlea for these patients. Here we examine whether this dosimetric advantage leads to a clinical benefit in audiometric outcomes....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Moeller, Benjamin J, Chintagumpala, Murali, Philip, Jimmy J, Grosshans, David R, McAleer, Mary F, Woo, Shiao Y, Gidley, Paul W, Vats, Tribhawan S, Mahajan, Anita
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3123575/
https://ncbi.nlm.nih.gov/pubmed/21635776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-6-58
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!